Abstract
Previous work showed that acute stimulation of a conditionally active protein kinase B (PKB or cAKT) was sufficient to elicit insulin-like induction of GCK (glucokinase) and SREBP1 (sterol regulatory element-binding protein 1) in hepatocytes [Iynedjian, Roth, Fleischmann and Gjinovci (2000) Biochem. J. 351, 621-627; Fleischmann and Iynedjian (2000) Biochem. J. 349, 13-17]. The objective of the present study was to determine whether activation of PKB during insulin stimulation of hepatocytes was a necessary condition for the induction of the two genes. Activation of PKB by insulin was inhibited by pretreatment of the hepatocytes with C2 ceramide. This resulted in the inhibition of insulin-dependent increases in GCK and SREBP1 mRNAs. A triple mutant of PKB failed to interfere with insulin activation of PKB in hepatocytes even at high overexpression levels achieved after adenovirus transduction. A PKB-CaaX fusion protein, which can act as a dominant-negative inhibitor of PKB activation in other cells, was shown to be constitutively activated in hepatocytes and to trigger insulin-like induction of GCK and SREBP1. In addition, constitutive PKB-CaaX activity caused refractoriness of the hepatocytes to insulin signalling at an upstream step resulting in the inhibition of both extracellular-signal-regulated kinase 1/2 and endogenous PKB activation. The stimulation of gene expression by constitutively active PKB-CaaX and inhibition of the insulin effect by ceramide are compatible with a role for PKB in the insulin-dependent induction of GCK and SREBP1.
Full Text
The Full Text of this article is available as a PDF (234.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Choi Kin Man, McMahon Lloyd P., Lawrence John C., Jr Two motifs in the translational repressor PHAS-I required for efficient phosphorylation by mammalian target of rapamycin and for recognition by raptor. J Biol Chem. 2003 Mar 28;278(22):19667–19673. doi: 10.1074/jbc.M301142200. [DOI] [PubMed] [Google Scholar]
- Coffer P. J., Jin J., Woodgett J. R. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J. 1998 Oct 1;335(Pt 1):1–13. doi: 10.1042/bj3350001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cross D. A., Alessi D. R., Cohen P., Andjelkovich M., Hemmings B. A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995 Dec 21;378(6559):785–789. doi: 10.1038/378785a0. [DOI] [PubMed] [Google Scholar]
- Fleischmann M., Iynedjian P. B. Regulation of sterol regulatory-element binding protein 1 gene expression in liver: role of insulin and protein kinase B/cAkt. Biochem J. 2000 Jul 1;349(Pt 1):13–17. doi: 10.1042/0264-6021:3490013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Foretz M., Guichard C., Ferré P., Foufelle F. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12737–12742. doi: 10.1073/pnas.96.22.12737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Foretz M., Pacot C., Dugail I., Lemarchand P., Guichard C., Le Lièpvre X., Berthelier-Lubrano C., Spiegelman B., Kim J. B., Ferré P. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol. 1999 May;19(5):3760–3768. doi: 10.1128/mcb.19.5.3760. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fort P., Marty L., Piechaczyk M., el Sabrouty S., Dani C., Jeanteur P., Blanchard J. M. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985 Mar 11;13(5):1431–1442. doi: 10.1093/nar/13.5.1431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Greene Michael W., Sakaue Hiroshi, Wang Lihong, Alessi Dario R., Roth Richard A. Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by Serine 312 phosphorylation. J Biol Chem. 2003 Jan 1;278(10):8199–8211. doi: 10.1074/jbc.M209153200. [DOI] [PubMed] [Google Scholar]
- Hajduch E., Balendran A., Batty I. H., Litherland G. J., Blair A. S., Downes C. P., Hundal H. S. Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia. 2001 Feb;44(2):173–183. doi: 10.1007/s001250051596. [DOI] [PubMed] [Google Scholar]
- Hayzer D. J., Iynedjian P. B. Alternative splicing of glucokinase mRNA in rat liver. Biochem J. 1990 Aug 15;270(1):261–263. doi: 10.1042/bj2700261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Iynedjian P. B., Hanson R. W. Increase in level of functional messenger RNA coding for phosphoenolpyruvate carboxykinase (GTP) during induction by cyclic adenosine 3':5'-monophosphate. J Biol Chem. 1977 Jan 25;252(2):655–662. [PubMed] [Google Scholar]
- Iynedjian P. B., Jotterand D., Nouspikel T., Asfari M., Pilot P. R. Transcriptional induction of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon-cAMP system. J Biol Chem. 1989 Dec 25;264(36):21824–21829. [PubMed] [Google Scholar]
- Iynedjian P. B. Mammalian glucokinase and its gene. Biochem J. 1993 Jul 1;293(Pt 1):1–13. doi: 10.1042/bj2930001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Iynedjian P. B., Marie S., Gjinovci A., Genin B., Deng S. P., Buhler L., Morel P., Mentha G. Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocytes. J Clin Invest. 1995 May;95(5):1966–1973. doi: 10.1172/JCI117880. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Iynedjian P. B., Roth R. A., Fleischmann M., Gjinovci A. Activation of protein kinase B/cAkt in hepatocytes is sufficient for the induction of expression of the gene encoding glucokinase. Biochem J. 2000 Nov 1;351(Pt 3):621–627. [PMC free article] [PubMed] [Google Scholar]
- Johnston Anne M., Pirola Luciano, Van Obberghen Emmanuel. Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling. FEBS Lett. 2003 Jul 3;546(1):32–36. doi: 10.1016/s0014-5793(03)00438-1. [DOI] [PubMed] [Google Scholar]
- Kolesnick Richard. The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest. 2002 Jul;110(1):3–8. doi: 10.1172/JCI16127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li J., DeFea K., Roth R. A. Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway. J Biol Chem. 1999 Apr 2;274(14):9351–9356. doi: 10.1074/jbc.274.14.9351. [DOI] [PubMed] [Google Scholar]
- Matsumoto Michihiro, Ogawa Wataru, Teshigawara Kiyoshi, Inoue Hiroshi, Miyake Kazuaki, Sakaue Hiroshi, Kasuga Masato. Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes. Diabetes. 2002 Jun;51(6):1672–1680. doi: 10.2337/diabetes.51.6.1672. [DOI] [PubMed] [Google Scholar]
- Michael M. D., Kulkarni R. N., Postic C., Previs S. F., Shulman G. I., Magnuson M. A., Kahn C. R. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell. 2000 Jul;6(1):87–97. [PubMed] [Google Scholar]
- Nouspikel T., Iynedjian P. B. Insulin signalling and regulation of glucokinase gene expression in cultured hepatocytes. Eur J Biochem. 1992 Nov 15;210(1):365–373. doi: 10.1111/j.1432-1033.1992.tb17430.x. [DOI] [PubMed] [Google Scholar]
- Ozes O. N., Akca H., Mayo L. D., Gustin J. A., Maehama T., Dixon J. E., Donner D. B. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc Natl Acad Sci U S A. 2001 Apr 3;98(8):4640–4645. doi: 10.1073/pnas.051042298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Potashnik R., Bloch-Damti A., Bashan N., Rudich A. IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress. Diabetologia. 2003 May 15;46(5):639–648. doi: 10.1007/s00125-003-1097-5. [DOI] [PubMed] [Google Scholar]
- Ravichandran L. V., Esposito D. L., Chen J., Quon M. J. Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. J Biol Chem. 2000 Nov 3;276(5):3543–3549. doi: 10.1074/jbc.M007231200. [DOI] [PubMed] [Google Scholar]
- Ribaux Pascale, Gjinovci Asllan, Sadowski Henry B., Iynedjian Patrick B. Discrimination between signaling pathways in regulation of specific gene expression by insulin and growth hormone in hepatocytes. Endocrinology. 2002 Oct;143(10):3766–3772. doi: 10.1210/en.2002-220304. [DOI] [PubMed] [Google Scholar]
- Scott P. H., Brunn G. J., Kohn A. D., Roth R. A., Lawrence J. C., Jr Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7772–7777. doi: 10.1073/pnas.95.13.7772. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shepherd P. R., Withers D. J., Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J. 1998 Aug 1;333(Pt 3):471–490. doi: 10.1042/bj3330471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stoeckman Angela K., Towle Howard C. The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression. J Biol Chem. 2002 May 16;277(30):27029–27035. doi: 10.1074/jbc.M202638200. [DOI] [PubMed] [Google Scholar]
- Stratford S., DeWald D. B., Summers S. A. Ceramide dissociates 3'-phosphoinositide production from pleckstrin homology domain translocation. Biochem J. 2001 Mar 1;354(Pt 2):359–368. doi: 10.1042/0264-6021:3540359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Teruel T., Hernandez R., Lorenzo M. Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes. 2001 Nov;50(11):2563–2571. doi: 10.2337/diabetes.50.11.2563. [DOI] [PubMed] [Google Scholar]
- Tontonoz P., Kim J. B., Graves R. A., Spiegelman B. M. ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol. 1993 Aug;13(8):4753–4759. doi: 10.1128/mcb.13.8.4753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vanhaesebroeck B., Alessi D. R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J. 2000 Mar 15;346(Pt 3):561–576. [PMC free article] [PubMed] [Google Scholar]
- Walker K. S., Deak M., Paterson A., Hudson K., Cohen P., Alessi D. R. Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha. Biochem J. 1998 Apr 1;331(Pt 1):299–308. doi: 10.1042/bj3310299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang Q., Somwar R., Bilan P. J., Liu Z., Jin J., Woodgett J. R., Klip A. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol. 1999 Jun;19(6):4008–4018. doi: 10.1128/mcb.19.6.4008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Blitterswijk Wim J., van der Luit Arnold H., Veldman Robert Jan, Verheij Marcel, Borst Jannie. Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem J. 2003 Jan 15;369(Pt 2):199–211. doi: 10.1042/BJ20021528. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Weeren P. C., de Bruyn K. M., de Vries-Smits A. M., van Lint J., Burgering B. M. Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. J Biol Chem. 1998 May 22;273(21):13150–13156. doi: 10.1074/jbc.273.21.13150. [DOI] [PubMed] [Google Scholar]